The Biotechnology Innovation Organization (BIO) has elected its new Executive Committee directors for the 2022-2023 term: with the directors chosen during the 2022 BIO International Convention in San Diego in June.
“On behalf of our entire BIO organization, I want to congratulate our incoming Board directors and section leaders,” said Dr. Michelle McMurry-Heath, President & CEO of BIO. “This is a critical time for our industry. Our BIO Board – especially one as diverse and multi-faceted as this one – will help drive policies that keeps pace with innovation’s promise to cure disease, nourish society, and protect our planet.”
BIO’s Executive Committee directors for the 2022-2023 term are:
Paul Hastings, Nkarta Therapeutics – Board Chair/Health Section Chair